Aquablation robotic therapy for lower urinary tract symptoms caused by benign prostatic hyperplasia

  • Medtech innovation briefing
  • MIB315
  • Published: 
Download (PDF)

Regulatory information

Aquablation therapy is a CE-marked class I, IIa and IIb medical device.